Issues: Numerous studies have been conducted to assess non-drinkers' reported reasons for abstinence, and this review summarises and compares the reasons for abstinence reported by lifelong abstainers, current abstainers and former problem-drinkers.
Approach: Based on a search of four computerised databases, we identified 31 relevant studies, each of which included a sample of at least 20 individuals who had been abstinent from alcohol for at least 14 days and reported a numerical summary of participants' self-reported reasons for not drinking. To identify the most salient reasons for abstinence among each group of abstainers, we calculated a z-score to represent the level of endorsement of each reason in each investigation, assigned listed reasons to one of 13 categories, and calculated average z-scores (weighted by study quality ratings) for each of the categories.
Key Findings: Having no interest in drinking and disliking the effects of alcohol were the most salient categories of reasons for lifelong abstainers; having no interest in drinking and health reasons were the most salient categories of reasons for current abstainers; and health reasons was the most salient category of reasons for former problem-drinkers.
Implications And Conclusions: Understanding the reasons that motivate abstinence from alcohol may help refine theoretical explanations of drinking and abstinence. In addition, understanding the reasons that lifelong abstainers report for not beginning to drink, and that current abstainers and former problem-drinkers report for no longer drinking, may help inform interventions designed either to delay the initiation of alcohol use or help individuals stop drinking.
Download full-text PDF |
Source |
---|---|
http://dx.doi.org/10.1111/dar.13119 | DOI Listing |
Healthcare (Basel)
December 2024
Brightside Health, San Francisco, CA 94131, USA.
Background: Substance use disorders (SUDs) remain a growing public health issue, with drug- and alcohol-related deaths continuing to increase. A myriad of barriers prevent many with SUDs from seeking care. Telehealth interventions are well-positioned to reduce barriers and increase engagement in SUD treatment.
View Article and Find Full Text PDFJ Subst Use Addict Treat
December 2024
Department of Social and Behavioral Sciences, School of Global Public Health, New York University, New York, NY 10003, USA; Center for Drug Use and HIV/HCV Research, School of Global Public Health, New York University, New York, NY 10003, USA.
Introduction: Opioid withdrawal is a regular occurrence for many people who use illicit opioids (PWUIO) involving acute physical and psychological pain. Yet, there is very little data on the withdrawal experience of people in methadone maintenance treatment (MMT) and almost none from the patients' experience. Learning more about patients' withdrawal experiences can help to inform policies and practices that are better suited to address withdrawal and may improve patient satisfaction as well as uptake and retention.
View Article and Find Full Text PDFJ Subst Use Addict Treat
December 2024
The University of Manchester, Manchester Centre for Health Psychology, Division of Psychology and Mental Health, School of Health Sciences, Faculty of Biology, Medicine and Health, Manchester, UK; Manchester University NHS Foundation Trust, Manchester Academic Health Science Centre, Manchester, UK.
Introduction: Smoking prevalence rates in prison are typically four times higher than the rates found within community-based settings, increasing premature mortality. Encouraging smokers to self-administer incentives contingent on abstinence (i.e.
View Article and Find Full Text PDFDrug Alcohol Depend Rep
December 2024
Department of Psychology, Indiana University Indianapolis, Indianapolis, IN, United States.
Research has primarily studied reasons for quitting and/or reducing alcohol use in non-treatment samples. This systematic review aimed to characterize the reasons for quitting and/or reducing alcohol use among those who have received treatment for AUD and examine how reasons endorsed differ across measurement methods used. Articles were identified through PsycINFO, Web of Science, PubMed, and CINAHL.
View Article and Find Full Text PDFJ Addict Med
December 2024
From the Department of Family Medicine, Center for Behavioral and Addiction Medicine, University of California Los Angeles, Los Angeles, CA (JASW, GVCC, SS, JM); Departments of Medicine and Surgery, University of California Los Angeles, Los Angeles, CA (AS, SS); Pfleger Liver Institute, Transplant Hepatology, University of California Los Angeles, Los Angeles, CA (AS, DE, SS); and Department of Care Coordination and Clinical Social Work, University of California Los Angeles, Los Angeles, CA (DE).
Phosphatidylethanol (PEth) testing is becoming increasingly common as a tool to assess for alcohol consumption in the practice of addiction medicine. Its potential to be an objective measure of ethanol exposure is appealing; however, the field has yet to develop a complete understanding of the factors that can influence a PEth level. Here we describe 3 patient cases in which blood transfusion within the preceding 28 days was the reason that PEth studies were positive in patients undergoing liver transplant evaluation.
View Article and Find Full Text PDFEnter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!